Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes-Reference-Cited by-同舟云学术

Breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes

Published:2015-07-26 Issue:1 Volume:153 Page:183-190
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Mutter Robert W.,Frost Marlene H.,Hoskin Tanya L.,Johnson Joanne L.,Hartmann Lynn C.,Boughey Judy C.

Funder

U.S. Department of Defense

Division of Cancer Prevention, National Cancer Institute

National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-015-3515-z.pdf

Reference25 articles.

1. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol 25(33):5203–5209 (Epub 2007 Oct 22)

2. Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ et al (2009) Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27(9):1362–1367 (Epub 2009 Feb 17)

3. Yao K, Stewart AK, Winchester DJ, Winchester DP (2010) Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998–2007. Ann Surg Oncol 17(10):2554–2562 (Epub 2010 May 12)

4. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van ‘t Veer L, Garber JE et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 22(6):1055–1062 (Epub 2004 Feb 23)

5. Meijers-Heijboer H, van Geel B, van Putten WL, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MB et al (2001) Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345(3):159–164

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postoperative Outcomes of Pre-Pectoral Versus Sub-Pectoral Implant Immediate Breast Reconstruction;Cancers;2024-03-12

2. Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer";BMC Cancer;2023-03-28

3. Effective Communication About Pregnancy, Birth, Lactation, Breastfeeding and Newborn Care: The Importance of Sexed Language;Frontiers in Global Women's Health;2022-02-07

4. Surgical Risk Reduction, Breast Cancer and Childbearing;Current Breast Cancer Reports;2021-07-27

5. Assessing the additional surgical risk of contralateral prophylactic mastectomy and immediate breast implant reconstruction;Breast Cancer Research and Treatment;2019-10-11